This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bodell, W. J. Articles by Banerjee, M. R. Search for Related Content PubMed PubMed Citation Articles by Bodell, W. J. Articles by Banerjee, M. R.

DNA Repair in Normal and Preneoplastic Mammary Tissues¹

Tumor Biology Laboratory, School of Life Sciences, University of Nebraska, Lincoln, Nebraska 68588

The purpose of this investigation was to obtain a comparative measure of DNA repair synthesis in hormone-dependent normal mammary tissue and hormone-independent D₁ hyperplastic alveolar nodule (HAN) outgrowth. Treatment of mammary fragments in culture with 5 mM hydroxyurea inhibits 98% of the semiconservative DNA synthesis. Treatment of mammary fragments with methyl methanesulfonate in the presence of hydroxyurea results in a 4- to 7-fold higher incorporation of [³H]deoxythymidine into the mammary cell DNA than does treatment with hydroxyurea alone. This hydroxyurea-resistant alkylating agent-induced [³H]deoxythymidine incorporation was studied by CsCl density gradient centrifugation and has been found to represent DNA repair replication. Similar levels of repair replication were found in both normal and preneoplastic D₁-HAN outgrowth. Autoradiographic analysis of mammary fragments and D₁-HAN outgrowth treated with methyl methanesulfonate plus hydroxyurea revealed that 30 to 50% of the epithelial cell nuclei were lightly labeled. No detectable repair synthesis was found in fat or stromal cells. The average number of grains per labeled nuclei was the same for both explants. These results suggest that a reduced DNA repair capacity is not associated with the increased sensitivity of D₁-HAN outgrowth to the tumorigenic effect of chemical carcinogens.

¹ The research was supported by Department of Health, Education and Welfare Grant CA 11058 and Contract NIH-NO1-CP 33289 from the National Cancer Institute.

² Present address: Department of Molecular Biology and Virus Laboratory, University of California, Berkeley, Calif. 94720.

³ To whom requests for reprints should be addressed.

Received 5/24/77. Accepted 12/13/77.